echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The international new coronavirus candidate vaccine will be presented at the 3rd Expo

    The international new coronavirus candidate vaccine will be presented at the 3rd Expo

    • Last Update: 2020-12-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The 3rd China International Import Expo will be held in Shanghai from November 5th to 10th, and the 3rd China International Import Expo will be one of the most important exhibitions in the world this year.
    , a nearly 130-year-old global headquarters in Mercedon, N.J., announced on September 25th that as the world's leading biopharmaceutical company, it had signed a three-year memorandum of cooperation with China Import Expo, demonstrating its long-term commitment to the Expo and to China. The China International Import Expo Bureau awarded the title of President of the "Public Health Epidemic Prevention Professional
    Association" in Meshadong to affirm its leading position and leading role in the industry, as well as its active efforts in the fight against the epidemic and its constructive role in strengthening the public health epidemic prevention system.
    As one of the largest multinational exhibitors at the Expo, Mercedong will this year present its long-standing work in China with more than 1000 square meters of physical and online booths, to visit the government, scientific research institutions and other institutions of professionals as well as online audiences, to fully display its long-term work in China's important milestones, focusing on the introduction of vaccines, diabetes, anti-infection and cancer and other areas of research and development highlights.
    has a history of vaccine development for more than 100 years, and since the outbreak of neo-crown pneumonia, Mercedon has launched a number of major research programs around the world to combat the new coronavirus. Several anti-neo-coronavirus will be on display for the first time at the third session of the research project, including two new crown pneumonia vaccines and a new coronary pneumonia oral antiviral drug EIDD-2801. The "100-Year History of Epidemic Resistance" will look back at the history of human resistance to polio, various influenza viruses, HIV viruses, and hepatitis B viruses, demonstrating the enormous contribution of science, innovation and cooperation to the maintenance of human health, including the Ebola virus vaccine, which was approved in the United States at the end of 2019.
    "We highly recognize the important value of the Expo as a platform, and as the president of the Expo's 'Public Health And Epidemic Prevention Professional
    Association, we will work with other multinational enterprises and partners to strengthen exchanges, interaction and resource sharing, and jointly support innovation and share opportunities for the Expo, so as not to remain committed to supporting the Chinese government in achieving the 'Healthy China 2030' goal," said Luo Wanli, president of Merca East China. "
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.